Synopsis
Request and interpret RF, anti-CCP and ANA only after defining a compatible clinical phenotype, using likelihood, titre, pattern and confirmatory tests without diagnosing autoimmune disease from an isolated antibody.
- RF is usually an IgM autoantibody directed against the Fc portion of IgG; it occurs in rheumatoid arthritis but also with age, chronic infection, smoking, other autoimmune disease and in some healthy people.
- Anti-CCP antibodies are more specific for rheumatoid arthritis and carry prognostic information, but a negative result does not exclude seronegative disease.
- Offer RF when clinical examination confirms synovitis and consider anti-CCP if RF is negative; never delay rheumatology referral while waiting for either result.
- ANA is a sensitive entry test for several connective-tissue diseases but has limited positive predictive value when ordered for fatigue or widespread pain without systemic features.
- Interpret ANA titre and laboratory pattern with symptoms, examination, FBC, renal function, urinalysis, complement and disease-specific antibodies.
- A positive ANA does not equal lupus, and a negative ANA makes some ANA-associated diseases less likely without excluding every connective-tissue or inflammatory condition.
- Repeating a positive antibody simply to monitor disease activity is usually unhelpful; follow clinical and organ-specific measures instead.
- Explain incidental results in plain language and document the remaining diagnostic uncertainty to prevent an unsupported autoimmune label following the patient indefinitely.
Key red flags
Proteinuria, active urine sediment, haemoptysis, hypoxia, myocarditis, severe cytopenia or neurological dysfunction requires urgent organ assessment regardless of antibody status.
Investigation priorities
Support diagnosis and prognosis when rheumatoid arthritis is suspected from persistent synovitis.
Management branches
Examination confirms persistent joint swelling compatible with rheumatoid arthritis.
- Request RF and consider anti-CCP with baseline FBC, renal and liver tests, while documenting joint distribution, duration and function.
- Send rheumatology referral immediately rather than waiting for the results, because negative serology and normal markers do not exclude disease.
- Interpret positive antibodies as probability and prognostic evidence within the specialist assessment, not as permission for unsupervised long-term immunosuppression.